Furthermore, the results of the present study showed that circulating serum AnxA2 levels had the potential to distinguish breast cancer patients from normal healthy females, which suggest the potential value of serum AnxA2 as a diagnostic biomarker for breast cancer [32]. The gene discussed is ANXA2; the disease is breast carcinoma.